Memry Corporation Added To Russell Microcap Index

BETHEL, Conn., July 5 /PRNewswire-FirstCall/ -- Memry Corporation announced today that it has joined the Russell Microcap(TM) Index published by Russell Investment Group. The Index was posted Monday, July 3 at http://www.russell.com .

Memry CEO Bob Belcher said, “The listing on the Russell Microcap Index widens the awareness of our company among investors as it places us among the top microcap companies on Wall Street. Russell closely tracks the holdings of approximately 30 active microcap managers, and this recognition will help us gain exposure with a broader range of investors.”

Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for both passive and active investment strategies. An industry-leading $3.8 trillion in assets currently are benchmarked to them. Investment managers who oversee these funds purchase shares of members’ stocks according to that company’s weighting in the particular index.

About the Russell Microcap Index

Russell, a global leader in multi-manager investment services, provides investment products and services in 44 countries. Russell manages more than $167 billion in assets and advises clients worldwide representing more $2.4 trillion. Founded in 1936, Russell is a subsidiary of Northwestern Mutual and is headquartered in Tacoma, Wash., with additional offices in New York, Toronto, London, Paris, Singapore, Sydney, Auckland and Tokyo. For more information, visit http://www.russell.com .

About Memry Corporation

Memry Corporation provides design, engineering, development and manufacturing services to the medical device and other industries using the company’s proprietary shape memory alloy and polymer extrusion technologies. Medical device products include stent components, catheter components, guidewires, laparoscopic surgical sub-assemblies and orthopedic instruments as well as complex, multi-lumen, multi-layer polymer extrusions used for guidewires, catheters, delivery systems and various other high-end interventional medical devices. Detailed information about Memry Corporation can be found at http://www.memry.com .

An investment profile on Memry Corporation may be found at http://www.hawkassociates.com/memry/profile.php .

For more information, contact CEO Robert P. Belcher at (203) 739-1100, e-mail: Robert_Belcher@memry.com , or Frank Hawkins or Julie Marshall, Hawk Associates, Inc., at (305) 451-1888, e-mail: info@hawkassociates.com . Copies of Memry Corporation press releases, SEC filings, current price quotes, stock charts and other valuable information for investors may be found at http://www.hawkassociates.com and http://www.americanmicrocaps.com .

This release contains certain forward-looking statements that involve known and unknown risks, uncertainties or other factors not under the company’s control, which may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations implied by these forward-looking statements. These factors include, but are not limited to, those detailed in the company’s periodic filings with the Securities and Exchange Commission.

Memry Corporation

CONTACT: Robert P. Belcher, CEO, Memry Corporation, +1-203-739-1100, orRobert_Belcher@memry.com; or Frank Hawkins or Julie Marshall, HawkAssociates, Inc., +1-305-451-1888, or info@hawkassociates.com, for MemryCorporation

MORE ON THIS TOPIC